


To achieve capital growth whilst maintaining a reasonable yield through a diversified Investments largely in equity markets with a bias towards UK and international equities, fixed income securities issued by governments, corporations and bank deposits.
| Name | % Net Assets | 
|---|---|
| HSBC | 6.3% | 
| HSBC | 5.4% | 
| GlaxoSmithKline | 4.1% | 
| Imperial Tobacco | 3.5% | 
| Unilever | 3.5% | 
| Standard Chartered | 3.4% | 
| BP | 3.3% | 
| BG | 3.2% | 
| BHP Billiton | 3.0% | 
| Anglo American | 2.8% | 
| Key | % Net Assets | 
|---|---|
| 6.3% | |
| 5.4% | |
| 4.1% | |
| 3.5% | |
| 80.7% | 
| Date | 19-Aug-2025 | 
|---|---|
| NAV | 201.75p | 
| Currency | GBP | 
| Change | 0.39p | 
| % | 0.19% | 
| YTD change | 4.65p | 
| YTD % | 2.36% | 
| Fund Inception | 01/06/1999 | 
|---|---|
| Fund Manager | Alan Custis / Gabrielle Boyle / Ian Smart and teams | 
| TER | 1.55 (31-Mar-2014) | 
| Minimum Investment | |
|---|---|
| Initial | £2000 | 
| Additional | £500 | 
| Savings | £75 | 
| Charges | |
|---|---|
| Initial | 3.75% | 
| Annual Mang't | 1.25% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.01 | 
| Sharpe ratio | 0.06 | 
You are here: research